ITMI20042187A1 - Derivati isossazolici per allievare il dolore neiropatico - Google Patents

Derivati isossazolici per allievare il dolore neiropatico

Info

Publication number
ITMI20042187A1
ITMI20042187A1 IT002187A ITMI20042187A ITMI20042187A1 IT MI20042187 A1 ITMI20042187 A1 IT MI20042187A1 IT 002187 A IT002187 A IT 002187A IT MI20042187 A ITMI20042187 A IT MI20042187A IT MI20042187 A1 ITMI20042187 A1 IT MI20042187A1
Authority
IT
Italy
Prior art keywords
pain
neiropathic
isossazolic
born
derivatives
Prior art date
Application number
IT002187A
Other languages
English (en)
Inventor
Ermanno Moriggi
Mauro Napoletano
Original Assignee
Zambon Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zambon Spa filed Critical Zambon Spa
Priority to IT002187A priority Critical patent/ITMI20042187A1/it
Publication of ITMI20042187A1 publication Critical patent/ITMI20042187A1/it
Priority to ES05815995T priority patent/ES2331921T3/es
Priority to DK05815995T priority patent/DK1817029T3/da
Priority to AT05815995T priority patent/ATE442848T1/de
Priority to DE602005016711T priority patent/DE602005016711D1/de
Priority to PL05815995T priority patent/PL1817029T3/pl
Priority to EA200701086A priority patent/EA013905B1/ru
Priority to EP05815995A priority patent/EP1817029B1/en
Priority to RSP-2009/0477A priority patent/RS51020B/sr
Priority to PT05815995T priority patent/PT1817029E/pt
Priority to PCT/EP2005/055940 priority patent/WO2006053860A1/en
Priority to SI200530813T priority patent/SI1817029T1/sl
Priority to US11/718,935 priority patent/US7834040B2/en
Priority to CA2586664A priority patent/CA2586664C/en
Priority to HR20090592T priority patent/HRP20090592T1/hr
Priority to CY20091101263T priority patent/CY1110563T1/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/10—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D261/18—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IT002187A 2004-11-16 2004-11-16 Derivati isossazolici per allievare il dolore neiropatico ITMI20042187A1 (it)

Priority Applications (16)

Application Number Priority Date Filing Date Title
IT002187A ITMI20042187A1 (it) 2004-11-16 2004-11-16 Derivati isossazolici per allievare il dolore neiropatico
CA2586664A CA2586664C (en) 2004-11-16 2005-11-14 Isoxazolic derivative to relieve neuropathic pain
EA200701086A EA013905B1 (ru) 2004-11-16 2005-11-14 Производные изоксазола, их фармацевтические композиции и способ лечения невропатической боли
RSP-2009/0477A RS51020B (sr) 2004-11-16 2005-11-14 Izoksazolni derivat za ublažavanje neuropatskog bola
AT05815995T ATE442848T1 (de) 2004-11-16 2005-11-14 Isoxazolsäure-derivat zur linderung neuropathischer schmerzen
DE602005016711T DE602005016711D1 (de) 2004-11-16 2005-11-14 Isoxazolsäure-derivat zur linderung neuropathischer schmerzen
PL05815995T PL1817029T3 (pl) 2004-11-16 2005-11-14 Pochodna izoksazolowa do łagodzenia bólu neuropatycznego
ES05815995T ES2331921T3 (es) 2004-11-16 2005-11-14 Derivado isoxazolico para aliviar el dolor neuropatico.
EP05815995A EP1817029B1 (en) 2004-11-16 2005-11-14 Isoxazolic derivative to relieve neuropathic pain
DK05815995T DK1817029T3 (da) 2004-11-16 2005-11-14 Isoxazolderivat til lindring af neuropatiske smerter
PT05815995T PT1817029E (pt) 2004-11-16 2005-11-14 Derivado isoxazólico para o alívio de dores neuropáticas
PCT/EP2005/055940 WO2006053860A1 (en) 2004-11-16 2005-11-14 Isoxazolic derivative to relieve neuropathic pain
SI200530813T SI1817029T1 (sl) 2004-11-16 2005-11-14 Derivati izoksazola za lajĺ anje nevropatskih boleäśin
US11/718,935 US7834040B2 (en) 2004-11-16 2005-11-14 Isoxazolic derivative to relieve neuropathic pain
HR20090592T HRP20090592T1 (hr) 2004-11-16 2009-11-04 Izoksazolni derivat za ublažavanje neuropatskih bolova
CY20091101263T CY1110563T1 (el) 2004-11-16 2009-12-01 Παραγωγο του ισοξαζολικου οξεος για την ανακουφιση νευροπαθητικου πονου

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT002187A ITMI20042187A1 (it) 2004-11-16 2004-11-16 Derivati isossazolici per allievare il dolore neiropatico

Publications (1)

Publication Number Publication Date
ITMI20042187A1 true ITMI20042187A1 (it) 2005-02-16

Family

ID=35840677

Family Applications (1)

Application Number Title Priority Date Filing Date
IT002187A ITMI20042187A1 (it) 2004-11-16 2004-11-16 Derivati isossazolici per allievare il dolore neiropatico

Country Status (16)

Country Link
US (1) US7834040B2 (it)
EP (1) EP1817029B1 (it)
AT (1) ATE442848T1 (it)
CA (1) CA2586664C (it)
CY (1) CY1110563T1 (it)
DE (1) DE602005016711D1 (it)
DK (1) DK1817029T3 (it)
EA (1) EA013905B1 (it)
ES (1) ES2331921T3 (it)
HR (1) HRP20090592T1 (it)
IT (1) ITMI20042187A1 (it)
PL (1) PL1817029T3 (it)
PT (1) PT1817029E (it)
RS (1) RS51020B (it)
SI (1) SI1817029T1 (it)
WO (1) WO2006053860A1 (it)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4985428A (en) * 1987-05-20 1991-01-15 Zambon Group S.P.A. Isoxazoles with nootropic activity

Also Published As

Publication number Publication date
EA013905B1 (ru) 2010-08-30
HRP20090592T1 (hr) 2009-12-31
EP1817029B1 (en) 2009-09-16
EA200701086A1 (ru) 2007-12-28
EP1817029A1 (en) 2007-08-15
CA2586664C (en) 2012-09-18
CA2586664A1 (en) 2006-05-26
SI1817029T1 (sl) 2010-01-29
US20080108679A1 (en) 2008-05-08
DK1817029T3 (da) 2009-12-14
ES2331921T3 (es) 2010-01-20
WO2006053860A1 (en) 2006-05-26
RS51020B (sr) 2010-10-31
PL1817029T3 (pl) 2010-02-26
US7834040B2 (en) 2010-11-16
PT1817029E (pt) 2009-11-20
DE602005016711D1 (de) 2009-10-29
CY1110563T1 (el) 2015-04-29
ATE442848T1 (de) 2009-10-15

Similar Documents

Publication Publication Date Title
MX2020008616A (es) Rocio de fentanilo sublingual.
UA92000C2 (en) 1-benzylindole-2-carboxamide derivatives
DK2324008T3 (da) Diarylpyrazol som protein kinase inhibitorer
EA201070167A1 (ru) Замещенные производные индазола, активные как ингибиторы киназы
EA200970595A1 (ru) Производные замещенных индазолов, активные в качестве ингибиторов киназ
EA200870193A1 (ru) Цитотоксические агенты, включающие новые производные томаймицина, и их терапевтическое применение
DE602006012322D1 (de) Als androgen-rezeptor-modulatoren verwendbare tetrahydrocarbazol-derivate
CY1108690T1 (el) Υποκατεστημενες ν-αρυλοπυρρολιδινες ως επιλεκτικοι διαμορφωτες υποδοχεα ανδρογονων
EA200501849A1 (ru) Производные пиразолохиназолина: способ получения и применение в качестве ингибиторов киназ
ATE430744T1 (de) Thiazolylpiperidin-derivate nützlich als h3 rezeptor modulatoren
EA200970611A1 (ru) Замещенные пиразолохиназолиновые производные, способ их получения и их применение в качестве ингибиторов киназы
ECSP088974A (es) Derivados de imidazol pirimidina para el tratamiento de enfermedades relacionadas con la glicógeno sintasa quinasa (gsk3)
NO20061245L (no) Farmasoytiske sammensetninger og fremgangsmater omfattende kombinasjoner av 2-alkyliden-19-nor-vitamin D derivater og en bisfosfon
ATE410424T1 (de) Spirocyclische cyclohexan-derivate
TW200626158A (en) Naphthaline derivatives
CL2007003209A1 (es) Composicion que comprende una vacuna de flavivirus vivos atenuados; composicion que comprende un producto farmaceutico derivado de virus o proteina; un metodo para la elaboracion de una composicion terapeutica que comprende liofilizar las composicion
UA97348C2 (en) HETEROCYCLIC NF-kB INHIBITORS
EA200801580A1 (ru) Новые производные пирониндола и способ их получения
TW200637817A (en) 5-aminoindole derivatives
NO20074933L (no) Farmasoytisk sammensetning som innbefatter et indolylmaleimidderivat
EA201001747A1 (ru) Бензоксазиноновые производные, действующие в качестве агониста бета-2-адренорецептора, для лечения респираторных расстройств
EP1784173A4 (en) PHARMACEUTICAL COMPOSITION FOR PREVENTING AND TREATING METABOLIC BONE DISEASES CONTAINING ALPHA-ARYLMETHOXYACRYLATE DERIVATIVES
MX2009005798A (es) Recuperacion de apoplejia.
CR10410A (es) Carboxamidas sustituidas.
MX2009007038A (es) Derivados de mononitrato de isosorbida para el tratamiento de trastornos intestinales.